Optimal oncology phase I dose escalation designs – a simulation study

Oke Gerke, Harald Siedentop

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalStatistics in Medicine
Volume27
Issue number26
Pages (from-to)5329-5344
Number of pages16
ISSN0277-6715
DOIs
Publication statusPublished - 20. Nov 2008

Keywords

  • clinical trial; oncology; maximum tolerated dose; phase I; Bayesian ADEPT

Cite this